Sheikh Khalifa Medical City, managed by SEHA, serves as the flagship institution for Abu Dhabi Health Services Company. It is governed by its commitment to practice modern medicine to the same high standards as the best medical facilities in the world.

There are 711 beds in Sheikh Khalifa Medical City.

During the past decade, Sheikh Khalifa Medical City conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sheikh Khalifa Medical City" #1 collaborator was "Beijing Institute of Biological Products Co Ltd." with 4 trials as a collaborator, "China National Biotec Group Company Limited" with 4 trials as a collaborator, "Lanzhou Institute of Biological Products Co., Ltd" with 4 trials as a collaborator, "Abu Dhabi Health Services Company" with 1 trials as a collaborator and "Beijing Insitute of Biological Products Co., Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Sheikh Khalifa Medical City" are "COVID-19" (4 trials), "COVID-19 Pneumonia" (3 trials), "Coronavirus Infections" (3 trials), "Atrial Fibrillation" (1 trials) and "Cardiac Arrhythmias" (1 trials). Many other conditions were trialed in "Sheikh Khalifa Medical City" in a lesser frequency.

Most popular intervention types in "Sheikh Khalifa Medical City" are "Biological" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Inactivated COVID-19 vaccine (Vero cells)" (2 trials), "3 doses Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)" (1 trials), "BIBP-Rec-Vaccine" (1 trials), "COVID-19 vaccine (Vero cells)" (1 trials) and "Inactivated SARS-CoV-2 Vaccine (Vero cell)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sheikh Khalifa Medical City" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Sheikh Khalifa Medical City". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sheikh Khalifa Medical City, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sheikh Khalifa Medical City, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".